Number of patients (male/female) (n) | 116 (65/51) |
Age (years) | 62 ± 13 |
Body mass index (kg/m2) | 21.3 ± 3.3 |
Type 2 diabetes mellitus (+/−)(n) | 48/68 |
Treatment (%) | |
ARB/ACE inhibitor | 31.0 |
Iron therapy | 37.1 |
Systolic blood pressure (mmHg) | 149 ± 24 |
Diastolic blood pressure (mmHg) | 88 ± 16 |
Heart rate (/min) | 77 ± 12 |
Duration of hemodialysis (years) | 7.6 ± .2 |
Kt/V (range) | 1.10 ± 0.31 |
Hemoglobin A1c (%) | 5.4 ± 0.7 |
Glycated albumin (%) | 16.7 ± 3.8 |
Triglyceride (mg/dL) | 139 ± 110 |
Total cholesterol (mg/dL) | 169 ± 32 |
Low-density lipoprotein cholesterol (mg/dL) | 94 ± 26 |
High-density lipoprotein cholesterol (mg/dL) | 51 ± 19 |
Albumin (g/dL) | 3.8 ± 0.3 |
Creatinine (mg/dL) | 11.26 ± 3.08 |
Uric acid (mg/dL) | 6.9 ± 1.4 |
Urea nitrogen (mg/dL) | 62.9 ± 13.5 |
Corrected calcium (mg/dL) | 9.0 ± 0.8 |
Phosphate (mg/dL) | 5.7 ± 1.3 |
C-reactive protein (mg/dL) | 0.27 ± 0.79 |
β2-microglobumin (mg/L) | 24.9 ± 5.4 |
Total carnitine (μmol/L) | 44.5 ± 11.7 |
Free carnitine (μmol/L) | 28.6 ± 8.1 |
Acyl carnitine (μmol/L) | 15.9 ± 4.7 |
Acyl carnitine/free carnitine | 0.6 ± 0.1 |
Skin autofluorescence (arbitrary unit) | 3.4 ± 0.7 |
Left ventricular ejection fraction (%) | 66.9 ± 8.9 |